Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16542
Title: 'ProtecTion' from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?
Austin Authors: Wang, Luke L;Wallis, Christopher JD;Sathianathen, Niranjan;Lawrentschuk, Nathan;Murphy, Declan G;Nam, Robert;Moon, Daniel
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Australian Urology Associates, Malvern, Victoria, Australia
Department of Surgery, Central Clinical School, Monash University, Melbourne, Victoria, Australia
Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia
Department of Surgery, Austin Health, University of Melbourne, Melbourne, Victoria, Australia
Australian Prostate Cancer Research Centre, Epworth Healthcare, Richmond, Victoria, Australia
Issue Date: 4-Jan-2017
metadata.dc.date: 2017-01-04
Publication information: BJU International 2017; 119(4): 513-514
URI: http://ahro.austin.org.au/austinjspui/handle/1/16542
DOI: 10.1111/bju.13734
ORCID: 0000-0001-8553-5618
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27930856
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

2
checked on Dec 1, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.